Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2015 by Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Nabil Ahmed, Baylor College of Medicine
ClinicalTrials.gov Identifier:
First received: May 13, 2009
Last updated: October 30, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2030
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)